Humanized skeletal muscle in MYF5/MYOD/MYF6-null pig embryos.
Geunho MaengSatyabrata DasSarah M GreisingWuming GongBhairab N SinghStefan KrenDaniel MickelsonErik SkieOhad GafniJacob R SorensenCyprian V WeaverDaniel J GarryMary G GarryPublished in: Nature biomedical engineering (2021)
Because post-mortem human skeletal muscle is not viable, autologous muscle grafts are typically required in tissue reconstruction after muscle loss due to disease or injury. However, the use of autologous tissue often leads to donor-site morbidity. Here, we show that intraspecies and interspecies chimaeric pig embryos lacking native skeletal muscle can be produced by deleting the MYF5, MYOD and MYF6 genes in the embryos via CRISPR, followed by somatic-cell nuclear transfer and the delivery of exogenous cells (porcine blastomeres or human induced pluripotent stem cells) via blastocyst complementation. The generated intraspecies chimaeras were viable and displayed normal histology, morphology and function. Human:pig chimaeras generated with TP53-null human induced pluripotent stem cells led to higher chimaerism efficiency, with embryos collected at embryonic days 20 and 27 containing humanized muscle, as confirmed by immunohistochemical and molecular analyses. Human:pig chimaeras may facilitate the production of exogenic organs for research and xenotransplantation.
Keyphrases
- induced pluripotent stem cells
- skeletal muscle
- endothelial cells
- pluripotent stem cells
- insulin resistance
- stem cells
- type diabetes
- cell death
- gene expression
- adipose tissue
- crispr cas
- cell proliferation
- cell therapy
- oxidative stress
- induced apoptosis
- copy number
- single molecule
- platelet rich plasma
- dna methylation
- genome editing
- pi k akt